Laipu insulin is a recombinant human insulin analogue and one of the three fast-acting insulin analogues. Insulin Pro can be used in the research of hyperglycemia in diabetes.
Gestational diabetes mellitus (gestationaldiabetesmellitus) can lead to a variety of maternal and infant hazards such as fetal distress, hydramnios, severe cases, even cause miscarriage or stillbirth.…
Insulin glargine is a recombinant human insulin analogue, featuring stability, no peak, and long-lasting action. It has a low solubility in neutral solutions and can be completely dissolved in acidic …
Deter insulin is another new type of soluble long-acting human insulin analogue following insulin glargine. Developed by NovoNordisk, it was launched in Europe in 2004 and approved for the treatment o…
rulicity, a long-acting GLP-1 analogue developed by Eli Lilly for a single subcutaneous injection per week, was approved in the United States in September 2014 for the treatment of type 2 diabetes. St…
Lixiela is a glucagon-like peptide-1 (GLP-1) receptor agonist. GLP-1 is a hormone that helps normalize blood sugar levels. The safety and efficacy of this drug were evaluated in 10 clinical trials, wh…
Retalutide (LY3437943) is a glucose-dependent insulin-like polypeptide, an agonist of glucagon-like peptide 1 and glucagon receptors. The dose-response relationship in terms of side effects, safety an…
Liraglutide is a transparent and colorless solution. The dosage form is subcutaneous injection. Liraglutide, after more than 10 years of research and development, has numerous functions such as promot…
ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea